Melanoma Protocol - Pathology Reporting database

The FileMaker Pathology Reporting database is constructed to provide data entry specific to individual pathology protocols, with controlled field entryvia pop up value lists, check boxes and radio buttons. in addition to free text entry as appropriate to specific question answers (fields). In the Melanoma protocol, answer data is recorded for 67 questions in 5 groups. The following questions are structured for the Melanoma reporting protocol. Full size database data entry layout examples are provided via the list in the sidebar.

Patient Identification data fields

Family Name, Given Name, Gender, Date Of Birth, Patient Identifiers, Date of Request, Path Accession No., Requesting doctor name, Requesting doctor phone, Requesting doctor contacted

Clinical details data fields

Melanoma Site, Laterality, Clinical Diagnosis, Specimen Type, Previous Laboratory Name, Prior Lab. Accession. No., Previous Laboratory Biopsy Findings, History and timing of lesional trauma, biopsy, irritation or treatment with topical agent, A past history of melanoma?, Details: e.g. site, size, timing, treatment etc., Evidence of metastatic disease?, Describe:, Serum LDH, Other relevant history, Specimen orientation, Any clinically or dermatoscopically identified suspicious areas?, Describe:, Relevant diagnostic imaging results, Other comments

Macroscopic findings data fields

Specimen description, Specimen dimension: length mm:, Specimen dimension: width mm:, Specimen dimension: thickness mm:, Specimen orientation, Description of primary lesion, Evidence of other lesions, Description of evidence of other lesions, General macroscopic comments

Microscopic findings data fields

Diagnosis, Microscopic description, Breslow thickness, This is a minimum thickness, Surgical margins involved?, Location known?, Specify location:, Nearest peripheral margin to in-situ component, Nearest peripheral margin to invasive component, Distance from tumour to deep margin, Ulceration:, Extent of Ulceration, Mitotic rate of the dermal invasive melanoma, Microsatellites, Clark level, Lymphovascular invasion:, Tumour-infiltrating lymphocytes (TILs):, Intermediate/late regression:, Desmoplasia:, Extent (% of invasive component), Neurotropism, Evidence of an associated benign melanocytic lesion, Describe:, Growth pattern, Subtype

Synthesis and Overview data fields

AJCC melanoma tumour-node sub-category pT, Regional lymph nodes, Calculated diagnostic summary - editable, Overarching comment